ADEMEX and HEMO trials: Where are we going?

Blood Purification

Volumn 21, Issue 1, 2003, Pages 42-45

  Prichard, Sarah ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

ADEMEX; Adequacy; HEMO trial; Peritoneal dialysis

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; CREATININE CLEARANCE; DATA ANALYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PERITONEAL DIALYSIS; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZATION; TREATMENT INDICATION;

CLINICAL PROTOCOLS; HUMANS; PATIENT SELECTION; PERITONEAL DIALYSIS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0037261470     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067869     Document Type: Conference Paper

References (17)

1. Hull AR, Parker TF III: Proceedings from Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, Tex, Sept 15-17, 1989. Am J Kidney Dis 1990;15:375-383.
2. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
3. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
4. Port FK, Orzol SM, Held PJ, Wolfe RA: Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 1998;32(suppl 4):34-38.
5. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23: 272-282.
6. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-669.
7. Parker T, Husni L, Huang W, Lew N, Lowrie EG: Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
8. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. New York, National Kidney Foundation 1997, pp 42-49.
9. National Kidney Foundation, K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 2001;37(suppl 1):7-64.
10. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, for the Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
11. Churchill DN, Taylor DW, Keshaviah PR for the CANUSA study group: Adequacy of dialysis and nutrition in a continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
12. Churchill DN: The ADEMEX Study: Make haste slowly. J Am Soc Nephrol 2002;13:1415-1418.
13. Centres for Medicare & Medicaid Services: 2001 Annual Report: End Stage Renal Disease Clinical Performance Measures Project. Am J Kidney Dis 2002;39(suppl 2):1-98.
14. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
15. Pierratos A, Ouwendyk M, Francoeur R, et al: Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol 1998;5:859-868.
16. Traeger J, Galland R, Arkouche W, et al: Short daily hemodialysis: A four-year experience. Dial Transpl 2001;30:76-86.
17. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D: Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001;60:1555-1560.